Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
about
Vitamin D in hematological disorders and malignancies.Clinical experience using vitamin d and analogs in the treatment of myelodysplasia and acute myeloid leukemia: a review of the literature.The role of vitamin D in hematologic disease and stem cell transplantation.Is there a role for differentiating therapy in non-APL AML?Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.Vitamin D Control of Hematopoietic Cell Differentiation and Leukemia.Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
P2860
Q30275725-ADB883A1-CE62-483B-A992-714AED0C9812Q36417543-529F97CD-3137-4351-9F6C-6647F70C5D6AQ37050872-9EEEEF20-F9BE-4267-911C-D7F76C115270Q37815790-9A2F4954-7076-495F-9678-F8FB17408EEEQ38730810-082C9775-27BC-4E78-9A2C-233AE7CF99A4Q39037456-E6AC10BD-12C3-4E9C-97D2-164120245E59Q42598206-8A58FA5D-B862-4258-9CDA-21995D94E045
P2860
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@ast
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@en
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@nl
type
label
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@ast
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@en
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@nl
prefLabel
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@ast
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@en
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@nl
P2093
P2860
P1433
P1476
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome
@en
P2093
Adam Petrich
Howard Bailey
Kyungmann Kim
Mark Juckett
Nancy Turman
P2860
P356
10.1080/10428190701713648
P577
2008-01-01T00:00:00Z